The Japan cancer vaccines market is rapidly evolving, driven by the nation’s increasing focus on precision medicine, strong public-private partnerships in medical innovation, and rising awareness around cancer prevention and immunotherapy. Cancer remains a leading cause of death in Japan, accounting for over 375,000 fatalities annually, making it imperative to develop innovative treatment...